Methylone is a rapid-acting neuroplastogen with less off-target activity than MDMA
Frontiers in Neuroscience February 7, 2024 Jennifer Warner-Schmidt, Martin Stogniew, Blake Mandell et al. 6 citations
BackgroundPost-traumatic stress disorder (PTSD) is a highly prevalent psychiatric disorder that can become chronic and debilitating when left untreated. Available pharmacotherapies are limited, take weeks to show modest benefit and remain ineffective for up to 40% of patients. Methylone is currently in clinical development for the treatment of PTSD. Preclinical studies show rapid, robust and...